Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 907,000
+112,000 (14.09%)
At close: Mar 20, 2026
Sam Chun Dang Pharm. Market Cap
Sam Chun Dang Pharm. has a market cap or net worth of 21.09 trillion as of March 20, 2026. Its market cap has increased by 404.18% in one year.
Market Cap
21.09T
Enterprise Value
21.14T
Revenue
220.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
907,000.00
Market Cap Chart
Since September 11, 2001, Sam Chun Dang Pharm.'s market cap has increased from 3.32B to 21.09T, an increase of 635,288.64%. That is a compound annual growth rate of 42.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 21.09T | 290.11% |
| Dec 30, 2025 | 5.41T | 56.57% |
| Dec 30, 2024 | 3.45T | 96.33% |
| Dec 28, 2023 | 1.76T | 82.00% |
| Dec 29, 2022 | 966.58B | 1.04% |
| Dec 30, 2021 | 956.65B | -47.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.37T |
| Celltrion | 44.21T |
| ALTEOGEN | 19.25T |
| ABL Bio | 10.64T |
| SK Biopharmaceuticals | 7.64T |
| Peptron | 7.40T |
| Yuhan | 7.33T |
| LigaChem Biosciences | 7.28T |